154 related articles for article (PubMed ID: 1328975)
1. Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases.
Barakat RR; Rubin SC; Wong G; Saigo PE; Markman M; Hoskins WJ
Obstet Gynecol; 1992 Oct; 80(4):660-4. PubMed ID: 1328975
[TBL] [Abstract][Full Text] [Related]
2. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
5. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
6. Mixed mesodermal tumors of the ovary: a clinicopathologic study of 14 cases.
Dinh TV; Slavin RE; Bhagavan BS; Hannigan EV; Tiamson EM; Yandell RB
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):409-12. PubMed ID: 2841630
[TBL] [Abstract][Full Text] [Related]
7. [Malignant mixed mesodermal tumors of the ovary: a clinical analysis of 12 cases].
Li H; Shi S; Zhang W
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):460-2. PubMed ID: 10920946
[TBL] [Abstract][Full Text] [Related]
8. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
[TBL] [Abstract][Full Text] [Related]
10. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
11. Malignant mixed mesodermal tumor of the ovary: a report of 22 cases.
Dictor M
Obstet Gynecol; 1985 May; 65(5):720-4. PubMed ID: 2984621
[TBL] [Abstract][Full Text] [Related]
12. Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.
Le T; Krepart GV; Lotocki RJ; Heywood MS
Gynecol Oncol; 1997 May; 65(2):237-40. PubMed ID: 9159331
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery for stage IV epithelial ovarian cancer.
Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
[TBL] [Abstract][Full Text] [Related]
14. Malignant ovarian germ cell tumors: a single-institution experience.
Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
[TBL] [Abstract][Full Text] [Related]
15. Carcinosarcoma of the ovary-a case series.
Rutledge TL; Gold MA; McMeekin DS; Huh WK; Powell MA; Lewin SN; Mutch DG; Johnson GA; Walker JL; Mannel RS
Gynecol Oncol; 2006 Jan; 100(1):128-32. PubMed ID: 16213011
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.
Akahira JI; Yoshikawa H; Shimizu Y; Tsunematsu R; Hirakawa T; Kuramoto H; Shiromizu K; Kuzuya K; Kamura T; Kikuchi Y; Kodama S; Yamamoto K; Sato S
Gynecol Oncol; 2001 Jun; 81(3):398-403. PubMed ID: 11371128
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
[TBL] [Abstract][Full Text] [Related]
18. Outcome and prognostic factors in ovarian germ cell malignancies.
Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prognosis of epithelial ovarian cancer: five year multi-center study.
Khodabakhshi R; Yahyazadeh-Jabbari SH; Gohari MR; Shahidi J; Ameri A
Saudi Med J; 2008 Dec; 29(12):1735-8. PubMed ID: 19082223
[TBL] [Abstract][Full Text] [Related]
20. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
